Clenergen Corporation
OTC Bulletin Board : CRGE

Clenergen Corporation

October 26, 2009 08:00 ET

Biomass2Biopower Private Limited Announces Commencement of 250 Acres of High Density Biomass Trials of Eucalyptus, Casuarinas, and "Vanashree" (A Cloned Species of Tree From the Neem Family)

Biomass2Biopower Limited (B2B) is a research and development company formed under a partnership between Clenergen Corporation (OTCBB:CRGE) and Enhanced Biofuels and Technologies Private Limited (EBTi)

NEW YORK, NEW YORK--(Marketwire - Oct. 26, 2009) - B2B today announced that it had completed the first stage of its research and development program into the use of indigenous species of trees as viable sources of feedstock for the production of biomass for gasification power plant projects being implemented by Clenergen Corporation. The program will provide validation of the yield, production cycles and agronomy requirements and offer diversification to Clenergen's integrated feedstock supply chain. "Vanashree" has already demonstrated on existing small scale plantations an output in excess of 40 tons per acre after 2 years of growth in a variety of soil conditions and relatively low water irrigation requirements.

For the land being used for biomass feedstock cultivation, B2B will develop and produce proprietary Bio pesticides, Bio fertilizers and other high value commodities derived from the processing of various biomass resources. It is projected that under controlled agronomy practices and fertilization programs, yields will be increased by as much as 20% on an annual basis. Furthermore, B2B has evolved a highly integrated complimentary operational profile that embraces a team of scientific and technical skills drawn from some of the world's foremost Research, Academic, Industrial, policy and financial sectors.

In the first phase of its operations in India, Clenergen has reached agreement on the terms to acquire a 1.5MW/Hr biomass power plant in Namakkal, Tamilnadu which will be operational by year end 2009. The company will ramp up the capacity of this power plant to 10MW/Hr while installing two new biomass power projects: a 16MW/Hr in Tuticorin Tamilnadu and a 64MW/Hr in Karnataka. The total project cost of the new plants has been estimated at US$236 million. Clenergen's Tuticorin power plant is slated to be in commercial operation in the last quarter 2010. The company is proposing to raise US$83 million in equity financing from the Indian stock markets. The 16MW/Hr power plant will require 4,000 acres of land to cultivate biomass feedstock required for its 24/7 operation, of which 800 acres has already been secured under sublease. Local supplies of wood chips will be contracted until the cultivated feedstock's reach first harvest.

Clenergen has identified an efficient system of power generation using gasification technology/gas turbines generators and power generation through Pyrolisis/steam turbine generators. These systems can produce power, steam, hydrogen, chemicals and other important products through advanced gasification and Pyrolisis/combustion steam technologies. The company also produces high-density, short-rotation biomass crops on a commercial scale at a cost of production equivalent to or less than the price of coal (measured in energy terms - MMBtu) using a proprietary integrated farming model.

Commenting on the new Joint Venture Company, Mark Quinn, CEO of Clenergen said "The wealth of scientific knowledge of the Scientific Advisory Council provides Clenergen the best possible plant science resources for its feedstock cultivation program, along with a variety of alternative indigenous species of trees in India, which can be adopted for specific climatic conditions. B2B will generate revenue from the sale of its bio pesticides and bio fertilizers as well as out sourcing planting materials to third parties for the purpose of cultivating biomass feedstock on behalf of Clenergen Corporation".

Doctor Ganapathy Arumugam, Managing Director & Group Science Director of EBTI said "Our partnership with Clenergen allows for the commercialization of our classic science expertise in the field of Plant breeding, Agronomy, and Microbiology and can provide a strong foundation for the production and supply of high yielding indigenous planting materials and crop based bio inputs to increase the productivity per unit area for the cultivation of biomass a Non edible feedstock as a source of renewable energy".

About Clenergen Corporation

Clenergen Corporation is a publicly listed company on the OTC stock market (symbol CRGE). Clenergen offers strategic Clean Energy Generation projects to address the requirement for renewable and sustainable supplies of electricity. Clenergen has developed a unique modular system of co-gasification and localized plantation management.

Using proprietary and mixed biomass feedstock to implement sustainable supplies of clean energy to regional, independent clients and national grids. The "Distributed Environmental Power System" marries significant proprietary advancements in plant science with proven long standing engineering technologies to achieve this goal.

Notice Regarding Forward-Looking Statements

This press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to our ability to establish our company as one of the leading biomass energy generating companies globally.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with clean technologies; changes in the operating costs and changes in economic conditions and conditions in clean technologies. These forward-looking statements are made as of the date of this press release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance those beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our current and periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact Information

  • Clenergen Corporation
    Jessica Hatfield
    Communications Director
    0044 (0)207 739 0028
    0044 (0)207 657 3275 (FAX)